Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Sara Kangaspeska"'
Autor:
Susanne Hultsch, Matti Kankainen, Lassi Paavolainen, Ruusu-Maaria Kovanen, Elina Ikonen, Sara Kangaspeska, Vilja Pietiäinen, Olli Kallioniemi
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Tamoxifen treatment of estrogen receptor (ER)-positive breast cancer reduces mortality by 31%. However, over half of advanced ER-positive breast cancers are intrinsically resistant to tamoxifen and about 40% will acquire the resis
Externí odkaz:
https://doaj.org/article/c213cddea43e4757ba932cf82fd12a67
Autor:
Sara Kangaspeska, Susanne Hultsch, Henrik Edgren, Daniel Nicorici, Astrid Murumägi, Olli Kallioniemi
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48745 (2012)
RNA-sequencing and tailored bioinformatic methodologies have paved the way for identification of expressed fusion genes from the chaotic genomes of solid tumors. We have recently successfully exploited RNA-sequencing for the discovery of 24 novel fus
Externí odkaz:
https://doaj.org/article/56bbb7de650e4363bb668164fde7d365
Autor:
Olli Kallioniemi, Merja Perälä, Yvonne Ceder, Anders Bjartell, Daniel Nicorici, Henrik Edgren, Sara Kangaspeska, Anders Edsjö, Zandra Hagman, Rami Mäkelä, Pekka Kohonen, Anna Aakula, Suvi-Katri Leivonen, Päivi Östling
Supplementary Table 5 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92644c8bc96a75d9052c635d4aeb549
https://doi.org/10.1158/0008-5472.22389762.v1
https://doi.org/10.1158/0008-5472.22389762.v1
Autor:
Olli Kallioniemi, Merja Perälä, Yvonne Ceder, Anders Bjartell, Daniel Nicorici, Henrik Edgren, Sara Kangaspeska, Anders Edsjö, Zandra Hagman, Rami Mäkelä, Pekka Kohonen, Anna Aakula, Suvi-Katri Leivonen, Päivi Östling
Supplementary Table 6 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a606c7bcf96f501eafeaa0dfc0348393
https://doi.org/10.1158/0008-5472.22389759.v1
https://doi.org/10.1158/0008-5472.22389759.v1
Autor:
Olli Kallioniemi, Merja Perälä, Yvonne Ceder, Anders Bjartell, Daniel Nicorici, Henrik Edgren, Sara Kangaspeska, Anders Edsjö, Zandra Hagman, Rami Mäkelä, Pekka Kohonen, Anna Aakula, Suvi-Katri Leivonen, Päivi Östling
Supplementary Figures 1-2, Materials, Tables 1-4 and Table 7 from Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e5f2586649992bb3d9d9ad80389f7f7
https://doi.org/10.1158/0008-5472.22389765.v1
https://doi.org/10.1158/0008-5472.22389765.v1
Autor:
Olli Kallioniemi, Merja Perälä, Yvonne Ceder, Anders Bjartell, Daniel Nicorici, Henrik Edgren, Sara Kangaspeska, Anders Edsjö, Zandra Hagman, Rami Mäkelä, Pekka Kohonen, Anna Aakula, Suvi-Katri Leivonen, Päivi Östling
Androgen receptor (AR) is expressed in all stages of prostate cancer progression, including in castration-resistant tumors. Eliminating AR function continues to represent a focus of therapeutic investigation, but AR regulatory mechanisms remain poorl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f167067cc930337615dd6bc9b6227544
https://doi.org/10.1158/0008-5472.c.6502710.v1
https://doi.org/10.1158/0008-5472.c.6502710.v1
Autor:
Bretschneider, Nancy, Sara Kangaspeska, Seifert, Martin, Reid, George, Gannon, Frank, Denger, Stefanie
Publikováno v:
In Molecular Oncology 2008 2(2):182-190
Autor:
Assunta Sellitto, Valerio Gigantino, Malin Åkerfelt, Giorgio Giurato, Annamaria Salvati, Eugenio Morelli, Tuula A. Nyman, Domenico Memoli, Giovanni Nassa, Luciano Milanesi, Donatella Malanga, Elena Alexandrova, Sara Kangaspeska, Alessandro Weisz, Teresa Mirante, Matthias Nees, Francesca Rizzo, Roberta Tarallo
Publikováno v:
Science Advances (2019). doi:10.1126/sciadv.aav5590
info:cnr-pdr/source/autori:Nassa G, Salvati A, Tarallo R, Gigantino V, Alexandrova E, Memoli D, Sellitto A, Rizzo F, Malanga D, Mirante T, Morelli E, Nees M, Åkerfelt M, Kangaspeska S, Nyman TA, Milanesi L, Giurato G, Weisz A./titolo:Inhibition of histone methyltransferase DOT1L silences ER? gene and blocks proliferation of antiestrogen-resistant breast cancer cells/doi:10.1126%2Fsciadv.aav5590/rivista:Science Advances/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
Science Advances
info:cnr-pdr/source/autori:Nassa G, Salvati A, Tarallo R, Gigantino V, Alexandrova E, Memoli D, Sellitto A, Rizzo F, Malanga D, Mirante T, Morelli E, Nees M, Åkerfelt M, Kangaspeska S, Nyman TA, Milanesi L, Giurato G, Weisz A./titolo:Inhibition of histone methyltransferase DOT1L silences ER? gene and blocks proliferation of antiestrogen-resistant breast cancer cells/doi:10.1126%2Fsciadv.aav5590/rivista:Science Advances/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
Science Advances
Pharmacological inhibition of DOT1L blocks estrogen receptor signaling in breast cancer.
Breast cancer (BC) resistance to endocrine therapy results from constitutively active or aberrant estrogen receptor α (ERα) signaling, and ways to block E
Breast cancer (BC) resistance to endocrine therapy results from constitutively active or aberrant estrogen receptor α (ERα) signaling, and ways to block E
Autor:
Tero Aittokallio, Alok Jaiswal, Olli Kallioniemi, John Patrick Mpindi, Samuli Eldfors, Henrik Edgren, Sara Kangaspeska, Susanne Hultsch, Oscar Brück
Publikováno v:
BMC Cancer
Background The estrogen receptor (ER) inhibitor tamoxifen reduces breast cancer mortality by 31 % and has served as the standard treatment for ER-positive breast cancers for decades. However, 50 % of advanced ER-positive cancers display de novo resis
Autor:
John Patrick Mpindi, Bhagwan Yadav, Sara Kangaspeska, Tero Aittokallio, Astrid Murumägi, Päivi Östling, Olli Kallioniemi, Disha Malani, Akira Hirasawa, Prson Gautam, Krister Wennerberg
Publikováno v:
Nature. 540:E5-E6